Journal article
A randomized clinical trial of full-time alternate patching therapy for intermittent exotropia in children
Optometry and vision science, v 103(2), e70015
Feb 2026
PMID: 41926779
Abstract
To determine whether 3 months of prescribed full-time alternate patching is more effective than observation for intermittent exotropia (IXT) in children.
We enrolled 73 children aged 3 to <9 years with mean IXT distance control score (3 measures) ≥2 points (on a 0-5 [phoria constant tropia] scale) with at least one score ≥3, 4, or 5 (indicating spontaneous XT over 30-s observation) and a distance exodeviation of 15-50 prism diopters (Δ) by prism and alternate cover test (PACT), with the near deviation not exceeding the distance by > 10Δ. Children were randomly assigned to 3 months full-time patching (all waking hours, 7 days per week, alternating eyes) or observation. The primary outcome was change in mean distance IXT control at 3 months.
Baseline mean (SD) distance control for children assigned to full-time patching (N = 36) and observation (N = 37) were 3.6 (0.9) and 3.6 (0.9) points; mean distance PACT was 27Δ (9) and 27Δ (8), respectively. The 3-month visit was completed by 33 (92%) of 36 and 35 (95%) of 37 children assigned to full-time patching and observation. Mean patching adherence was 4.1 h per day (95% CI: 2.8-5.5, N = 20) by participants who returned temperature sensor occlusion dose monitors and 7.4 h per day (95% CI: 5.8-8.9, N = 33) by review of at-home calendars and interviews with parent and child. At 3 months, children in the patching group had greater improvement in mean distance control than the observation group: 0.9 (1.3) versus 0.2 (1.1) points (difference = 0.62 points, 95% CI: 0.04-1.20, p = 0.04). There was also greater improvement in mean distance PACT: 6 (7) versus 2 (7) Δ, difference = 4Δ (95% CI: 1-8, p = 0.02).
Three months of prescribed full-time alternate day patching improved distance control and magnitude of IXT in children 3-<9 years, despite mean adherence substantially less than the prescribed full-time regimen. Future studies should evaluate the durability of treatment effects and compare patching to other treatments.
Clinicaltrials.Gov, registered 14 July 2022, NCT05462821.
Metrics
1 Record Views
Details
- Title
- A randomized clinical trial of full-time alternate patching therapy for intermittent exotropia in children
- Creators
- Erin C Jenewein (Corresponding Author) - Drexel UniversityStephen P Christiansen - Boston Medical CenterYufeng Zhu - Jaeb Center for Health ResearchRaymond T Kraker - Jaeb Center for Health ResearchAdriana P Grigorian - Arkansas Children's HospitalDonny W Suh - University of California, IrvineAllison I Summers - Oregon Health & Science UniversitySilvia Han - Marshall B. Ketchum UniversityBahram Rahmani - Lurie Children's HospitalKatie S Connolly - Indiana University BloomingtonPatricia L Davis - Eye Care AssociatesJennifer H Fisher - University of California, BerkeleyYasmin F Javed - University of California, BerkeleyCourtney L Kraus - Johns Hopkins UniversitySudhi P Kurup - Lurie Children's HospitalStacy R Martinson - Virginia Eye ConsultantsMorgan C Ollinger - Southern College of OptometryRobert G Tauscher - University of Alabama at BirminghamMarilyn Vricella - SUNY College of OptometryWesley T Beaulieu - Jaeb Center for Health ResearchStacy L Pineles - California NanoSystems InstituteSusan A Cotter - Marshall B. Ketchum UniversityJonathan M Holmes - University of ArizonaKatherine K Weise - University of Alabama at BirminghamPediatric Eye Disease Investigator Group
- Publication Details
- Optometry and vision science, v 103(2), e70015
- Publisher
- Wiley
- Number of pages
- 12
- Grant note
- P30 EY010572 / NIH HHS EY024333 / NEI NIH HHS EY011751 / NEI NIH HHS Research to Prevent Blindness Malcolm M. Marquis, MD Endowed Fund for Innovation
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pennsylvania College of Optometry (PCO)
- Web of Science ID
- WOS:001753351700001
- Scopus ID
- 2-s2.0-105034962634
- Other Identifier
- 991022172458804721